Regeneron to deliver 750K therapy doses to US by July

Friday, 05. February 2021 15:53

Regeneron Pharmaceuticals Inc. confirmed on Friday at its post-earnings conference call that the company expects to deliver 750,000 doses of its antibody therapy to the United States by the end of June.

Regeneron's REGN-COV2 antibody cocktail, which first got into public awareness during Donald Trump's recovery from the disease, is considered to reduce viral load and the time to alleviate symptoms in non-hospitalized patients diagnozed with the COVID-19.

The American biotech company achieved an outstanding fourth quarter of 2020 when it comes to financial results, registering an annual increase in revenue of 30% and net income of 66%.

Related Links: Regeneron Pharmaceuticals Inc.
Breaking the News / ND